MedTrace Logo

Nasal Swab Objective and Statistical Evaluation (NOSE Study)

NCT07469670 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1179

Last updated 2026-03-13

No results posted yet for this study

Summary

Supply chain disruptions have led to shortages in test swabs which are used to collect respiratory samples. Lack of these test swabs can reduce a hospital or state's ability to test patients for COVID-19.

To address this shortage, many manufacturers, hospitals and individuals have designed non-traditional 3D printed swabs for COVID-19 diagnosis that could potentially meet demands for nasal swabs. However, questions regarding the safety and effectiveness of these swabs remain.

This study will provide additional, statistically supported evidence as to the safety and efficacy of novel swabs.

Conditions

  • SARS Coronavirus 2 RT-PCR Testing

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Joseph Iaquinto, PhD · VA Puget Sound Health Care System Seattle Division, Seattle, WA

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-05
Primary Completion
2022-08-16
Completion
2022-08-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07469670 on ClinicalTrials.gov